Atlas Venture Life Science Advisors, LLC Portfolio Holdings
Atlas Venture Life Science Advisors, LLC
- $606 Million
- Q4 2024
Atlas Venture Life Science Advisors, LLC has filed its 13F form on February 06, 2025 for Q4 2024 where it was disclosed a total value porftolio of $606 Million distributed in 13 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Kymera Therapeutics, Inc. with a value of $197M, Dyne Therapeutics, Inc. with a value of $189M, Third Harmonic Bio, Inc. with a value of $107M, Day One Biopharmaceuticals, Inc. with a value of $81.5M, and Vigil Neuroscience, Inc. with a value of $9.81M.
Examining the 13F form we can see an decrease of $204M in the current position value, from $810M to 606M.
Below you can find more details about Atlas Venture Life Science Advisors, LLC portfolio as well as his latest detailed transactions.